Yes, psoriasis patients can earn $100–$400 by participating in focus groups and clinical research studies. Companies conducting skin treatment research actively recruit participants with moderate to severe plaque psoriasis, offering monetary compensation alongside free study-related care and investigational treatments. For example, Portable Insights currently recruits participants ages 21-64 with moderate to severe plaque psoriasis or psoriatic arthritis for 60-minute telephone or web-based focus groups paying $125 per session—a straightforward way to earn money while contributing to dermatology research. The opportunity is substantial because the skin care research landscape is active.
As of 2025-2026, there are 34 active clinical trials recruiting volunteers for paid psoriasis research, with 15 focused specifically on plaque psoriasis. These studies evaluate emerging treatments like JNJ-77242113, deucravacitinib, and ORKA-001, as well as post-marketing safety studies for medications like apremilast in pediatric participants. Beyond clinical trials, focus group participants typically receive compensation for their time and travel expenses, though total earnings vary by study length, location, and trial phase. Understanding where these opportunities exist and what they entail requires knowing the difference between focus groups and clinical trials, which participate structures vary significantly.
Table of Contents
- Where Can Psoriasis Patients Find Paid Focus Group Opportunities?
- Understanding Compensation Structures and Payment Ranges
- Types of Psoriasis Studies Currently Recruiting
- Evaluating Study Eligibility and Application Process
- Risks, Side Effects, and Study Safety Considerations
- Maximizing Your Earnings and Managing Multiple Studies
- The Future of Psoriasis Research Participation
- Conclusion
Where Can Psoriasis Patients Find Paid Focus Group Opportunities?
Paid focus group opportunities for psoriasis patients are concentrated in specific regions and platforms. States with the highest trial availability include California, Ontario, Texas, and Florida—areas where pharmaceutical companies and research institutions maintain robust clinical research infrastructure. Online platforms and market research firms like Portable Insights specialize in recruiting patients with specific skin conditions, and clinical trial matching websites such as PolicyLab list active recruiting studies by condition and location. The availability of 15 dedicated plaque psoriasis trials reflects strong investment in dermatological research, particularly for this most common type of psoriasis. The recruitment process typically begins with a screening survey to confirm eligibility.
Most studies require participants to have a confirmed psoriasis diagnosis, meet specific age requirements (often 18 or older, though some pediatric studies exist), and have moderate to severe disease severity. A key advantage compared to general market research is that study-related care—including dermatological assessments, investigational treatments, and placebo comparisons—is provided at no cost to participants. This removes financial barriers for patients seeking treatment while they earn compensation. One limitation to be aware of is geographic constraints. Participants living in rural areas or regions with limited clinical research infrastructure may have fewer options. Additionally, studies often require multiple visits or monitoring periods, which may conflict with work schedules or require time off.
Understanding Compensation Structures and Payment Ranges
The $100–$400 range reflects different study types and commitment levels. Focus groups like the Portable Insights opportunity pay $125 for a single 60-minute session, making them accessible for participants who cannot commit to multi-visit clinical trials. In contrast, longer-term clinical trials may offer total compensation reaching $710 or more across multiple visits, though individual visit payments are typically $50–$200. International studies, such as academic research conducted in Europe, may offer compensation in local currency—for example, €50 (approximately $55) for clinical focus group participation in some studies. Payment timing varies by study. Most research organizations pay participants via check, direct deposit, or gift cards within 1–4 weeks after study completion.
Some studies pay per visit, while others disperse compensation at the end of the entire trial. It’s important to clarify payment terms during enrollment, particularly if you’re relying on the income for specific expenses. Additionally, the IRS may require reporting of clinical trial compensation as income if it exceeds $600 in a calendar year, depending on the study structure and your tax situation—something to discuss with a tax professional if you’re planning to participate in multiple studies. A significant downside is that compensation does not always reflect the true time investment. A study requiring four office visits, blood work, and weekly photo documentation may pay the same as a single focus group, even though the actual time commitment is substantially higher. Always calculate the hourly rate before committing.
Types of Psoriasis Studies Currently Recruiting
The current research pipeline reveals diverse study designs targeting different aspects of psoriasis treatment. Some studies evaluate brand-new investigational drugs like JNJ-77242113 and deucravacitinib in Phase 2 or Phase 3 trials, comparing them to placebo or existing treatments in participants with moderate to severe plaque psoriasis. These studies are typically longer (8–12 weeks or more) and require more frequent monitoring, but they often offer higher total compensation due to increased participant burden. Others focus on post-marketing safety surveillance, such as ongoing studies monitoring apremilast in pediatric participants ages 6–17 with mild to moderate plaque psoriasis, designed to detect long-term side effects after a drug has already been approved. Focus groups represent a smaller but faster segment of psoriasis research. These studies gather qualitative feedback on patient experiences with treatments, disease burden, medication side effects, and unmet needs.
They typically involve 6–12 participants discussing their psoriasis journeys with a moderator, lasting 60–90 minutes. The value of focus groups to pharmaceutical companies is high because they inform product development, marketing strategies, and patient support programs—yet participants often perceive them as less burdensome than clinical trials. For someone seeking straightforward compensation without extensive medical procedures, focus groups are an efficient option. A limitation of current studies is the emphasis on moderate to severe disease. Participants with mild psoriasis or limited psoriatic arthritis manifestations may be excluded from many high-paying trials. Additionally, studies recruiting for newer drugs may require washout periods (discontinuing current psoriasis medications), which can be uncomfortable and may not be feasible for patients with severe, uncontrolled disease.
Evaluating Study Eligibility and Application Process
Before applying to any psoriasis study, gather your medical documentation. You’ll need confirmation of your psoriasis diagnosis, ideally from a dermatology visit within the past 1–2 years. Studies also assess disease severity, typically using dermatologist assessment or validated scales like the Psoriasis Area and Severity Index (PASI). Having recent photos of affected areas and a list of current medications accelerates the screening process. Most online platforms like PolicyLab allow you to search by condition and location, filter by visit frequency, and view inclusion/exclusion criteria before submitting any personal information. The application process is usually straightforward: complete an online screening form, provide contact information, and wait for a research coordinator to call or email within 1–5 business days.
For focus groups, screening may take just 15 minutes and result in immediate qualification. For clinical trials, more rigorous screening follows, including phone interviews, medical history reviews, and sometimes a pre-study office visit. Once enrolled, you’ll receive detailed study instructions, compensation terms, and informed consent documents. Reading the informed consent carefully is essential—it explains potential risks, how your data will be used, and your right to withdraw at any time. One tradeoff is privacy: participating in research requires sharing detailed medical and personal information with research organizations and potentially pharmaceutical companies. While studies follow strict privacy regulations (such as HIPAA in the US), your health data becomes part of research databases. If you’re uncomfortable with this level of data sharing, focus groups requiring minimal testing may be more appropriate than invasive clinical trials.
Risks, Side Effects, and Study Safety Considerations
All clinical research carries potential risks, though they vary by study type. Focus groups have minimal risk—primarily the time commitment and potential emotional discomfort discussing your psoriasis condition. Clinical trials evaluating new drugs carry higher risks because the investigational treatment’s full safety profile may be unknown. Potential side effects could include skin reactions, allergic responses, or systemic effects depending on the drug’s mechanism of action. Reputable studies employ independent safety monitoring boards that review participant data and can halt a trial if safety concerns emerge. Before enrolling in a drug trial, research the investigational compound’s phase of development. Phase 1 and 2 trials test drug safety and initial efficacy in smaller groups (20–100 participants) and carry higher uncertainty.
Phase 3 trials involve larger populations (hundreds to thousands) with more established safety data. Studies evaluating established drugs like apremilast in new populations (such as pediatric safety studies) have lower risk profiles because the drug is already approved. The informed consent document will detail all known risks; don’t hesitate to ask the research coordinator questions if anything is unclear. A critical warning: never enroll in a study to treat active, severe psoriasis that requires immediate clinical care. While studies provide free treatment, delays in receiving the randomized treatment (especially if assigned placebo) could worsen your condition. Always maintain relationships with your regular dermatologist and discuss study participation with them. Some studies require your dermatologist’s approval or coordination of care during the study period.
Maximizing Your Earnings and Managing Multiple Studies
Earning the full $100–$400 range may require participation in multiple studies or longer-term commitments. Many participants strategically combine a quick focus group ($125 for one session) with a shorter clinical trial (8–12 weeks, $300–$400 total) to increase earnings while limiting overall time investment. However, most research institutions require a washout period between studies—typically 30 days—to prevent drug interactions or data contamination if you’re taking investigational medications.
Document your study participation for tax and medical record purposes. Keep receipts and correspondence from research organizations showing compensation amounts and dates. If you accumulate more than $600 in research compensation annually, the sponsoring organization will send you a Form 1099-NEC for tax reporting. Simultaneously, maintain a personal log of any side effects or observations during studies—this information is valuable for your dermatologist and helps establish whether symptoms are due to the investigational drug, your underlying condition, or other factors.
The Future of Psoriasis Research Participation
The psoriasis research landscape is expanding due to increasing investment in newer biologic and small-molecule therapies. As more drugs move through clinical development, participant demand will likely grow, potentially increasing compensation rates and study availability.
Remote and hybrid study models—like the telephone or web-based focus groups offered by Portable Insights—are becoming more common, reducing geographic barriers and making participation more accessible to patients in underserved areas. Additionally, patient advocacy organizations like the National Psoriasis Foundation increasingly promote research participation and help patients find opportunities aligned with their conditions and preferences. As awareness grows, the stigma around participating in paid research diminishes, and more psoriasis patients recognize research participation as a legitimate way to earn income while advancing dermatological science.
Conclusion
Psoriasis patients can realistically earn $100–$400 through focus groups and clinical research studies, with opportunities ranging from single 60-minute focus groups paying $125 to multi-week clinical trials offering $300–$400 in total compensation. With 34 active clinical trials and 15 plaque psoriasis-specific studies currently recruiting, availability is highest in California, Ontario, Texas, and Florida, though online platforms and remote focus groups are expanding access nationwide. Success requires gathering your medical documentation, carefully reviewing study protocols and compensation terms, and ensuring participation aligns with your current disease management plan.
To get started, visit clinical trial matching websites like PolicyLab, search your location and psoriasis type, and contact research coordinators for screening. If you prefer minimal commitment, focus groups offer quick compensation with low risk. If you can commit to longer-term studies and tolerate investigational treatments or placebos, clinical trials offer higher earnings and the added benefit of free dermatological care. In all cases, discuss any study participation with your current dermatologist to ensure coordinated care and safety.
